Comparative efficacy of Chinese patent medicines for non-alcoholic fatty liver disease: A network meta-analysis

Potential Roles and Key Mechanisms of Hawthorn Extract against Various Liver Diseases

(2022) Eujin Kim et al.   Nutrients

Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification

(2022) Guoyan Jiang et al.   Bioengineered

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

(2022) Kenneth Cusi et al.   Endocrine Practice

May Silymarin be selectively considered for nonalcoholic fatty liver disease without elevated transaminases? Comment re. “Impact of Silymarin in individuals with nonalcoholic fatty liver disease: a systematic review and meta-analysis”

(2022) Lu Liu et al.   NUTRITION

Schisandra chinensis essential oil attenuates acetaminophen-induced liver injury through alleviating oxidative stress and activating autophagy

(2022) Jing Zhao et al.   PHARMACEUTICAL BIOLOGY

Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats

(2022) Yuan Zhou et al.   Frontiers in Pharmacology

Protective effects of maslinic acid on high fat diet-induced liver injury in mice

(2022) Tianqi Li et al.   LIFE SCIENCES

Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy

(2022) Wenling Zhou et al.   PHYTOMEDICINE

Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice

(2022) Zhuohui Zhao et al.   Nutrients

Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis

(2022) Lianjie Xu et al.   Evidence-based Complementary and Alternative Medicine

Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice

(2022) Ling-Cui Meng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

Vitamin E: How much is enough, too much and why!

(2021) Maret G. Traber et al.   FREE RADICAL BIOLOGY AND MEDICINE

The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice

(2021) Geng-Ruei Chang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review

(2021) Yoshihiro Kamada et al.   JOURNAL OF GASTROENTEROLOGY

The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial

(2021) Maryam jarhahzadeh et al.   Diabetology & Metabolic Syndrome

Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response

(2020) Qiaoling Yang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Nonalcoholic Steatohepatitis

(2020) Adam C. Sheka et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review

(2020) Xiao Ma et al.   Frontiers in Pharmacology

Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice

(2020) Songtao Li et al.   Frontiers in Pharmacology

Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa

(2020) Gamal Shiha et al.   Lancet Gastroenterology & Hepatology

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2018) Zobair M. Younossi et al.   HEPATOLOGY

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

(2018) Andrea Cipriani et al.   LANCET

Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)

(2018) Jian Gao Fan et al.   Journal of Digestive Diseases

Polyphenols from hawthorn peels and fleshes differently mitigate dyslipidemia, inflammation and oxidative stress in association with modulation of liver injury in high fructose diet-fed mice

(2016) Xiao Han et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway

(2016) Zhihong Ma et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Protective and therapeutic effects of Crataegus aronia in non-alcoholic fatty liver disease

(2016) Suliman Al Humayed   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice

(2013) Wei-Hsuan Hsu et al.   FOOD AND CHEMICAL TOXICOLOGY

Effect of Xuezhikang Capsule (血脂康胶囊) on serum tumor necrosis factor-α and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia

(2010) Xiao-fen Fan et al.   Chinese Journal of Integrative Medicine

Treatment of non-alcoholic fatty liver disease by Qianggan Capsule (强肝胶囊)

(2010) Li Li et al.   Chinese Journal of Integrative Medicine